• Welcome, Guest. Please login or register.
    July 02, 2020, 07:08:46 AM

  • Login with username, password and session length

Sajid's dove

Tell everyone they can now find this site by typing this into their browser:


Click to visit us on Facebook

If you have any problems registering or signing in, please send an email to: andythalpal@yahoo.com
Please do not send questions about thalassemia to this address.


Thalassemia Patients and Friends and thalpal Ā© A. Battaglia 2019

55311 Posts in 5912 Topics by 6212 Members
Latest Member: Pocatju

Forum Tip: 
You can now simply type thalpal.com into your browser and it will take you to this site. Tell your friends about this easy-to-remember name.
« previous next »
Pages: 1 Go Down Print
Author Topic: Gene Transfer Therapy Clinical Trials at Sloan Kettering (stage 1)  (Read 2906 times)
Active Member
Offline Offline

Posts: 75

« on: October 28, 2012, 05:38:02 PM »

I was so encouraged to read this. For those of us who would not attempt a BMT (with or without a perfect sibling match), this (if successful) would truly be a "cure" without risking host v. graft. The patient's OWN stem cells would be used. Hoping the vector being used in these clinical trials will have better results than previous one(s) (as they caused cancer...)


My son, adopted from China at age 3 in April 2010, has beta thalassemia major.
Thal Major.
Supreme Member
Offline Offline

Location: India.

Gender: Male
Posts: 826

« Reply #1 on: October 29, 2012, 01:26:35 AM »

This is very amazing, I would be so glad to hear about the results when more patients are recruited.

Every child is special.
Pages: 1 Go Up Print 
« previous next »
Jump to:  

Powered by MySQL Powered by PHP Powered by SMF 1.1.21 | SMF © 2015, Simple Machines Valid XHTML 1.0! Valid CSS!